Who is Reached by HIV Self-Testing? Individual Factors Associated With Self-Testing Within a Community-Based Program in Rural Malawi.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
01 10 2020
Historique:
pubmed: 6 6 2020
medline: 31 3 2021
entrez: 6 6 2020
Statut: ppublish

Résumé

HIV self-testing (HIVST) is an alternative strategy for reaching population subgroups underserved by available HIV testing services. We assessed individual factors associated with ever HIVST within a community-based program. Malawi. We conducted secondary analysis of an end line survey administered under a cluster-randomized trial of community-based distribution of HIVST kits. We estimated prevalence differences and prevalence ratios (PRs) stratified by sex for the outcome: self-reported ever HIVST. Prevalence of ever HIVST was 45.0% (475/1055) among men and 40.1% (584/1456) among women. Age was associated with ever HIVST in both men and women, with evidence of a strong declining trend across categories of age. Compared with adults aged 25-39 years, HIVST was lowest among adults aged 40 years and older for both men [34.4%, 121/352; PR 0.74, 95% confidence interval (CI): 0.62 to 0.88] and women (30.0%, 136/454; PR 0.71, 95% CI: 0.6 to 0.84). Women who were married, had children, had higher levels of education, or were wealthier were more likely to self-test. Men who had condomless sex in the past 3 months (47.9%, 279/582) reported a higher HIVST prevalence compared with men who did not have recent condomless sex (43.1%, 94/218; adjusted PR 1.37, 95% CI: 1.06 to 1.76). Among men and women, the level of previous exposure to HIV testing and household HIVST uptake was associated with HIVST. Community-based HIVST reached men, younger age groups, and some at-risk individuals. HIVST was lowest among older adults and individuals with less previous exposure to HIV testing, suggesting the presence of ongoing barriers to HIV testing.

Identifiants

pubmed: 32501815
doi: 10.1097/QAI.0000000000002412
pii: 00126334-202010010-00006
pmc: PMC7611247
mid: EMS127428
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-173

Subventions

Organisme : Wellcome Trust
ID : 200901
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 091769
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200901/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 074644
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT091769
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 060983
Pays : United Kingdom

Références

Lancet HIV. 2019 Feb;6(2):e81-e92
pubmed: 30584047
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Global Health. 2011 May 15;7:13
pubmed: 21575149
AIDS. 2012 Jan 28;26(3):365-73
pubmed: 22095194
Curr Opin Infect Dis. 2018 Feb;31(1):14-24
pubmed: 29232277
Pediatr Res. 2016 Jun;79(6):838-45
pubmed: 26882367
Curr Opin HIV AIDS. 2018 May;13(3):257-264
pubmed: 29401121
Ann Am Thorac Soc. 2019 Jan;16(1):22-28
pubmed: 30230362
Int Migr. 1998;36(4):445-68
pubmed: 12295093
BMC Public Health. 2013 Mar 11;13:220
pubmed: 23497196
Arch Pediatr Adolesc Med. 2009 May;163(5):438-45
pubmed: 19414690
PLoS Med. 2019 Jan 2;16(1):e1002719
pubmed: 30601823
BMC Public Health. 2014 Jan 13;14:33
pubmed: 24417763
Infect Dis Poverty. 2016 Sep 06;5(1):92
pubmed: 27595846
AIDS. 2017 Jul 1;31 Suppl 3:S203-S212
pubmed: 28665878
AIDS Behav. 2017 Apr;21(4):1171-1182
pubmed: 27506817
J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):355-364
pubmed: 32195749
BMC Public Health. 2018 Nov 6;18(1):1234
pubmed: 30400959
PLoS Med. 2015 Sep 08;12(9):e1001873
pubmed: 26348035
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
J Int AIDS Soc. 2011 Jun 09;14:29
pubmed: 21658260
J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25255
pubmed: 30907499
Trop Med Int Health. 2016 Nov;21(11):1442-1451
pubmed: 27714902
PLoS Med. 2016 Nov 8;13(11):e1002166
pubmed: 27824882
BMC Med. 2016 Feb 19;14:34
pubmed: 26891969
J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25245
pubmed: 30907515
Lancet HIV. 2016 Jun;3(6):e266-74
pubmed: 27240789
BMC Geriatr. 2018 Oct 25;18(1):257
pubmed: 30359223
BMC Health Serv Res. 2015 Jun 30;15:250
pubmed: 26123133

Auteurs

Pitchaya P Indravudh (PP)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Malawi-Liverpool-Wellcome Trust Clinical Research Program, Blantyre, Malawi.

Bernadette Hensen (B)

Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Rebecca Nzawa (R)

Malawi-Liverpool-Wellcome Trust Clinical Research Program, Blantyre, Malawi.

Richard Chilongosi (R)

Population Services International, Lilongwe, Malawi.

Rose Nyirenda (R)

Department of HIV and AIDS, Ministry of Health, Lilongwe, Malawi.

Cheryl C Johnson (CC)

Global HIV, hepatitis and sexually transmitted infections programs, World Health Organization, Geneva, Switzerland.

Karin Hatzold (K)

Population Services International, Washington D.C.; and.

Katherine Fielding (K)

Department of Infectious Disease Epidemiology and MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Elizabeth L Corbett (EL)

Malawi-Liverpool-Wellcome Trust Clinical Research Program, Blantyre, Malawi.
Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Melissa Neuman (M)

Department of Infectious Disease Epidemiology and MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH